Aligos Therapeutics Ownership | Who Owns Aligos Therapeutics?

Overview Forecast RevenueFinancials Chart

Aligos Therapeutics Ownership Summary

Aligos Therapeutics is owned by 26.15% institutional investors, 10.37% insiders, and 63.48% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 4.29% of ALGS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.40% of its assets in Aligos Therapeutics shares.

ALGS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aligos Therapeutics	26.15%	10.37%	63.48%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Deep track capital, lp	444.11K	4.29%	$3.20M
Alyeska investment group	412.00K	3.98%	$2.97M
Sio capital management	335.94K	3.25%	$2.42M
Tang capital management	141.13K	1.36%	$1.02M
Adage capital partners gp	140.00K	1.35%	$1.01M
Readystate asset management lp	136.78K	1.32%	$986.20K
Baker bros. advisors lp	83.06K	0.80%	$598.83K
Hhlr advisors	76.25K	0.74%	$549.74K
Bank of america corp /de/	816.03K	0.52%	$285.61K
Geode capital management	405.69K	0.26%	$142.02K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sio capital management	335.94K	0.93%	$2.42M
Deep track capital, lp	444.11K	0.10%	$3.20M
Tang capital management	141.13K	0.05%	$1.02M
Readystate asset management lp	136.78K	0.03%	$986.20K
Hhlr advisors	76.25K	0.02%	$549.74K
Alyeska investment group	412.00K	0.01%	$2.97M
Baker bros. advisors lp	83.06K	0.01%	$598.83K
Xtx topco	13.85K	0.00%	$99.85K
Adage capital partners gp	140.00K	0.00%	$1.01M
Virtu financial	12.31K	0.00%	$4.00K

Top Buyers

Holder	Shares	% Assets	Change
Sio capital management	335.94K	0.93%	155.22K
Readystate asset management lp	136.78K	0.03%	91.38K
Geode capital management	405.69K	-	32.64K
Xtx topco	13.85K	0.00%	13.85K
Virtu financial	12.31K	0.00%	12.31K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-7.26M
Ecor1 capital	-	-	-6.39M
Vanguard group	-	-	-1.60M
Versant venture management	-	-	-1.46M
Opaleye management	-	-	-1.26M

New Positions

Holder	Shares	% Assets	Change	Value
Xtx topco	13.85K	0.00%	13.85K	$99.85K
Virtu financial	12.31K	0.00%	12.31K	$4.00K
Acadian asset management	3.91K	0.00%	3.91K	$28.00K
Raymond james financial	500.00	-	500.00	$3.60K

Sold Out

Holder	Change
Qube research	-2.00
Nelson, van denburg & campbell wealth management group	-80.00
Spire wealth management	-200.00
Wells fargo & company/mn	-298.00
Simplex trading	-1.10K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	37	5.71%	2,706,888	-15.60%	26	1.80%	19	-9.52%	8	-
Mar 31, 2025	35	2.94%	3,295,608	103.61%	39	5.89%	20	-9.09%	8	166.67%
Dec 31, 2024	1	-	80	-	-	-	1	-	-	-
Jun 30, 2024	48	-5.88%	47,289,231	2.33%	30	0.59%	17	-29.17%	13	160.00%
Mar 31, 2024	51	27.50%	46,213,782	1.91%	71	0.66%	24	41.18%	5	-28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	97.53K	1.40%	-2.13K
Vanguard US Total Market Shares ETF	52.80K	0.86%	-
Vanguard Institutional Extnd Mkt Idx Tr	42.24K	0.61%	3.06K
Schwab US Small-Cap ETF™	25.35K	0.41%	-7.00
Fidelity Extended Market Index	13.91K	0.23%	-36.00
Fidelity Total Market Index	7.61K	0.12%	3.27K
Spartan Extended Market Index Pool F	5.32K	0.09%	2.64K
Extended Equity Market Fund K	5.22K	0.09%	-104.00
Fidelity Series Total Market Index	3.76K	0.06%	-1.34K
NT Ext Equity Mkt Idx Fd - L	2.87K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 25, 2023	Nuechterlein Carole		Buy	$6.00M
Oct 25, 2023	Nuechterlein Carole		Buy	$3.00M
Oct 20, 2020	Novo Holdings A/S	-	Buy	$3.00M
Oct 20, 2020	Woiwode Thomas	-	Buy	$3.00M
Oct 20, 2020	Vivo Capital VIII, LLC	-	Buy	$7.25M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-

ALGS Ownership FAQ

Who Owns Aligos Therapeutics?

Aligos Therapeutics shareholders are primarily institutional investors at 26.15%, followed by 10.37% insiders and 63.48% retail investors. The average institutional ownership in Aligos Therapeutics's industry, Biotech Stocks , is 306.59%, which Aligos Therapeutics falls below.

Who owns the most shares of Aligos Therapeutics?

Aligos Therapeutics’s largest shareholders are Deep track capital, lp (444.11K shares, 4.29%), Alyeska investment group (412K shares, 3.98%), and Sio capital management (335.94K shares, 3.25%). Together, they hold 11.52% of Aligos Therapeutics’s total shares outstanding.

Does Blackrock own Aligos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aligos Therapeutics.

Who is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested?

Sio capital management is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.93% of its assets in 335.94K Aligos Therapeutics shares, valued at 2.42M$.

Who is the top mutual fund holder of Aligos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aligos Therapeutics shares, with 1.40% of its total shares outstanding invested in 97.53K Aligos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools